SNWV
SANUWAVE Health, Inc. Common Stock
Latest price
As of Oct 30, 2026, 4:00 PM EDT · Market data by Massive
Market cap
$45.3M
Volume
11.9K
Previous close
$5.27
Day range
$4.96 – $5.23
Listed
Oct 8, 2008
Coverage
24 articles
Price performance
Recent trading
Newsroom
Latest SNWV coverage
SANUWAVE Health Reports Stockholder Approval of SEPA Merger at Special Meeting of Stockholders
[ad_1] At a special meeting of stockholders on February 21, 2024, SANUWAVE stockholders approved the business combination with SEP Acquisition Corp. by a vote of 798,379,869 “for” and 5,221,765 “against” with 71,525 abstaining 70.5% of all shares eligible to vote in this special election either voted or abstained Of those who voted, 99.3% voted “for” ...
SANUWAVE Health Announces Preliminary Revenue Results for the Fourth Quarter and Fiscal Year 2023, Ended December 31, 2023
[ad_1] SANUWAVE is pleased to announce preliminary revenues of $6.6 million to $6.8 million for the fourth quarter ended December 31, 2023. This represents a new quarterly revenue record for the Company. Q4 2023 revenue increased 20% to 24% over Q4 2022 and in excess of 30% versus the third quarter of 2023. Preliminary FY ...
SANUWAVE Announces Q3 2023 Financial Results
[ad_1] EDEN PRAIRIE, MN – (NewMediaWire) – November 10, 2023 – SANUWAVE Health, Inc. (the “Company” or “SANUWAVE”) (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products, today announced its 3rd quarter 2023 results. For the three months ended September 30, 2023: ● Revenue for the three months ended Septe
SANUWAVE Will Host a Conference Call on November 10, 2023 at 8:00 AM (ET) to Present the Q3 2023 Financial Results
[ad_1] EDEN PRAIRIE, MN – (NewMediaWire) – November 08, 2023 – SANUWAVE Health, Inc. (OTCQB: SNWV), a leading provider of next-generation wound care products, will host a live conference call on Friday, November 10, 2023, at 8:00AM (ET) to present the Q3 2023 financial results. Telephone access to the call will be available by dialing the
SANUWAVE Health, Inc., a Leading Provider of FDA Approved Next-Generation Wound Care Products, Enters into a Merger Agreement with Sweat Equity Partners and Mercury Life Sciences-affiliated SEP Acquisition Corp., a Nasdaq-Listed Company
[ad_1] · SANUWAVE Health Inc. (OTCQB: SNWV) has entered into a definitive merger agreement with SEP Acquisition Corp. (Nasdaq: SEPA). Upon closing, the combined company is expected to trade on the Nasdaq Capital Market under the symbol “SNWV”. · The combined company expects to receive approximately $13.0 million of gross proceeds at closing, includ
SANUWAVE Announces Q2 2023 Financial Results
[ad_1] EDEN PRAIRIE, MN – (NewMediaWire) – August 11, 2023 – SANUWAVE Health, Inc. (the “Company” or “SANUWAVE”) (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products, today announced its 2nd quarter 2023 results. For the three months ended June 30, 2023: Revenue for the three months ended June 30, 2023 total
SANUWAVE Will Host a Live Conference Call on August 11, 2023 at 8:30 AM (EDT) to Present Its Q2 2023 Financial Results
[ad_1] EDEN PRAIRIE, MN – (NewMediaWire) – August 09, 2023 – SANUWAVE Health, Inc. (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products, will host a live conference call on Friday, August 11, 2023, at 8:30AM (EDT) to present its Q2 2023 financial results. Telephone access to the call will be available by dia
SANUWAVE Health, Inc. Appoints Morgan Frank as Chief Executive Officer
[ad_1] Frank Brings 29 Years of Experience in Life Sciences, Technology, and Capital Markets Kevin Richardson to Remain at SANUWAVE as Chief Strategic Officer and as a Member of the Board of Directors EDEN PRAIRIE, MN – (NewMediaWire) – May 24, 2023 – via NewMediaWire – SANUWAVE Health, Inc. (the "Company" or "SANUWAVE”) (OTCQB:SNWV), a lea
SANUWAVE Announces Q1 2023 Financial Results
[ad_1] EDEN PRAIRIE, MN – (NewMediaWire) – May 12, 2023 – SANUWAVE Health, Inc. (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products, today announced 1st quarter 2023 results. For the three-months ended March 31, 2023: Revenues increased 18% to $3.8 million for Q1 2023 versus $3.2 million for the same period
SANUWAVE Announces Chief Financial Officer
[ad_1] SANUWAVE Health, Inc. today announced the appointment of Dr. Toni Rinow as CFO Eden Prairie, MN – (NewMediaWire) – August 16, 2022 – SANUWAVE Health, Inc. (OTCPK: SNWV), a leading provider of next-generation wound care products, today announced the appointment of Dr. Toni Rinow, MBA as Chief Financial Officer (CFO). “With SEC ...
SANUWAVE Health Reports Second Quarter 2022 Financial Results & Will Host Live Conference Call With Business Update
[ad_1] Eden Prairie, MN – (NewMediaWire) – August 15, 2022 – SANUWAVE Health, Inc. (OTCPK: SNWV), a leading provider of next-generation wound care products, reported financial results for their second quarter ending June 30, 2022, with the SEC on Friday, August 12, 2022. The Company will host a live conference call on Tuesday, August 16, ..
SANUWAVE Treats Football Legend Jim McMahon With ENERGY FIRST
[ad_1] Suwanee, GA – (NewMediaWire) – July 22, 2022 – SANUWAVE Health, Inc. (OTCQB: SNWV), a Medical Device Company Specializing in Chronic Wound Care, Helps Treat Football Legend Jim McMahon with their ENERGY FIRST devices dermaPACE® and UltraMIST®. Jim McMahon Jr. is a former football quarterback and college hall-of-famer, who played in t
NewMediaWire | SANUWAVE Business Update
[ad_1] Sales Funnel and System Trials Increase 13% Month Over Month Launches Entry into Two New Vertical Markets; Initial Orders Exceed $1 million SUWANEE, GA – (NewMediaWire) – April 08, 2022 – SANUWAVE Health, Inc. (SNWV), a leading provider of next-generation wound care products, has announced they will be updating shareholders on a mont
SANUWAVE Health to Host Conference Call and Provide Business Update
[ad_1] SUWANEE, GA – (NewMediaWire) – October 20, 2021 – SANUWAVE Health, Inc. (SNWV), a leading provider of next-generation wound care products, announced it will hold a conference call on Friday, October 22, 2021, at 9:00 am ET to discuss its recent business activity, provide an update on SEC filings and detail strateg
SANUWAVE Health to Present Energy First Solutions at Upcoming Wound Care Industry Conferences
[ad_1] Suwanee, GA – (NewMediaWire) – April 16, 2021 – SANUWAVE Health, Inc. (OTCQB: SNWV), a leading provider of next-generation wound care products, announced today that the Company will be participating in a number of leading wound care industry conferences – both virtual and in-person – where it will highlight the clinical merits of its
SANUWAVE Health Announces Expansion of Ametus Group Distribution Partnership
[ad_1] Agreement Incorporates SANUWAVE’s Entire Wound Care Product Portfolio Suwanee, GA – (NewMediaWire) – March 30, 2021 – SANUWAVE Health, Inc. (OTCQB: SNWV), focused on the development and commercialization of a robust and innovative advanced wound care product portfolio for the repair and regeneration of skin and vascular structures, a
SANUWAVE Health Announces Exclusive Distribution Agreement for Southeast Asia with Leading Taiwanese Medical Device Distributor Kingdom Brother
[ad_1] Partnership Further Extends the Availability of SANUWAVE’s Energy-Based Medical Systems to a Region with the Second Highest Prevalence of Diabetes in the World Suwanee, GA – (NewMediaWire) – March 29, 2021 – SANUWAVE Health, Inc. (OTCQB: SNWV), focused on the development and commercialization of a robust and innovative advanced w
SANUWAVE Health Secures Customer Medical Device Financing
[ad_1] A CIT Facility Helps Expand the Market for SANUWAVE’s Products Suwanee, GA – (NewMediaWire) – March 24, 2021 – SANUWAVE Health, Inc. (OTCQB: SNWV), focused on the development and commercialization of a robust and innovative advanced wound care product portfolio for the repair and regeneration of skin and vascular structures, announ
SANUWAVE Health Announces Distribution Agreement with Labb Solutions
[ad_1] SANUWAVE to Distribute dermaPACE® System and UltraMIST® System in Turkey and in Select Eastern Europe and Middle East Countries Suwanee, GA – (NewMediaWire) – March 19, 2021 – SANUWAVE Health, Inc. (OTCQB: SNWV), focused on the development and commercialization of a robust and innovative advanced wound care product portfolio for the
SANUWAVE Health Reports Increased Reimbursement Payments for UltraMist and dermaPACE in 2021
[ad_1] Underscores continued medical need for and clinical utility of SANUWAVE Health's energy transfer therapeutics in advanced wound care Suwanee, GA – (NewMediaWire) – December 23, 2020 – SANUWAVE Health, Inc. (OTCQB: SNWV), focused on the development and commercialization of a robust and innovative advanced wound care product portfolio
SANUWAVE Health to Participate in LD Micro Main Event XIII
[ad_1] Highlights Significant Growth in Wound Care Franchise at Premier Small Cap Investor Conference Fourth Quarter 2020 Product Revenue to Grow 50% Sequentially; Fiscal 2021 Revenue to Increase More Than 300% Suwanee, GA – (NewMediaWire) – December 11, 2020 – SANUWAVE Health, Inc. (OTCQB: SNWV), focused on the development and commerciali
SANUWAVE Health Announces Regulatory Clearance for dermaPACE in Mexico by the Federal Commission for Protection against Sanitary Risks (COFEPRIS)
[ad_1] Forms Joint Venture with MEDSTENT, S.A. to Market dermaPACE in Mexico to Treat a Variety of Chronic Wounds Suwanee, Ga – (NewMediaWire) – October 14, 2020 – SANUWAVE Health, Inc. (OTCQB: SNWV), focused on the development and commercialization of a robust and innovative advanced wound care product portfolio for the repair and regenera
NewMediaWire | CORRECTION – SANUWAVE Health Announces Reimbursement Coverage for BIOVANCE From Largest Medicare and Medicaid Administrator in U.S.
[ad_1] 24.5 Million Covered Lives Now Eligible for Biologic Advanced Wound Care Treatment Through Centene Corporation Suwanee, Ga – (NewMediaWire) – September 09, 2020 – SANUWAVE Health, Inc. (OTCQB: SNWV), whose focus is the development and commercialization of a robust and innovative advanced wound care product po
SANUWAVE Health to Participate in Upcoming September Investor Conferences
[ad_1] Management to Highlight Significant Opportunities with Recent Acquisition of Celularity’s UltraMIST assets and Preview Plans for Balance of 2020 Suwanee, GA – (NewMediaWire) – August 27, 2020 – SANUWAVE Health, Inc. (OTCQB: SNWV), whose focus is the development and commercialization of a robust and innovative advanced wound care pr